Found 14 matching trials
PET/MRI to Stage Prostate Cancer Patients
PHASE2The main goal of this phase II clinical trial is to define a novel approach...
Location
IRCCS Ospedale San Raffaele
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
PHASE1The aim of this study is to investigate safety and diagnostic performance o...
Location
Krankenhaus der Barmherzigen Schwestern
The LightPath® and 68Ga-RM2 in Breast Cancer Study
PHASE3This study is a prospective, open-label study to examine the performance of...
Location
Guy's and St Thomas' NHS Foundation Trust
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
PHASE2Prostate cancer (PC) remains the most-common non-cutaneous cancer diagnosed...
Location
Stanford University, School of Medicine
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy
PHASE1This study is being conducted to determine whether the combination of imagi...
Location
Stanford University
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
PHASE2The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2...
Location
Stanford University
HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer
PHASE2This study is being conducted to determine whether the combination of imagi...
Location
Stanford Cancer Center
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
PHASE2This clinical trial studies the use of gallium-68 (68Ga)-DOTA-Bombesin as t...
Location
Stanford University Hospitals and Clinics
68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
PHASE2The purpose of this study is to see if a new diagnostic research agent name...
Location
Memorial Sloan Kettering Cancer Center
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
PHASE1This trial studies how well 68-Ga RM2 works with PET/MRI in imaging patient...
Location
Stanford Cancer Institute Palo Alto